InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Wellington Biomedical Innovation Master Investors (Cayman) I L.P.. Insider active across 6 companies, notably Verve Therapeutics, Inc.. Cumulatively, 6 reports have been logged. Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
180,635 sharesCommon StockSEC:0001104659-24-101030:0
145,089 sharesCommon StockSEC:0001415889-24-019908:0
189,933 sharesCommon StockSEC:0001415889-24-009885:0
888,130 sharesCommon StockSEC:0000950170-22-025513:0
897,671 sharesClass A Common StockSEC:0000899243-21-031393:0
1,343,081 sharesCommon StockSEC:0000899243-21-025303:0
6 of 6 declarations
About Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is a declarant with 8 filings in total. Among the most recent filings held in the sample, they cover the period from 2021-06-22 to 2024-09-18, with 0 EUR of buys and 0 EUR of sells, and relate to Nuvalent, Inc., Verve Therapeutics, Inc., Zenas BioPharma, Inc., Artiva Biotherapeutics, Inc., Boundless Bio, Inc., and Acrivon Therapeutics, Inc.
